4Filing Date: Apr 2, 2026

Guardant Health (GH) 4: Talasaz AmirAli bought 2,817 shares of Common Stock at $N/A… (Apr 2, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001753159-26-000008
Total Value$1.69M
Trades8
Insiders1

Transaction Details

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Exercise · Acquire
Common Stock
Shares+24.00K
Price$0.00
Total Value$0
Shares Owned After2.15M
Transaction DateApr 1, 2026
Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-9.72K
Price$0.00
Total Value$0
Shares Owned After68.01K
Transaction DateApr 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-24.00K
Price$0.00
Total Value$0
Shares Owned After71.99K
Transaction DateApr 1, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Tax W/H · Dispose
Common Stock
Shares-17.09K
Price$91.15
Total Value$1.56M
Shares Owned After2.15M
Transaction DateApr 1, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Exercise · Acquire
Common Stock
Shares+9.72K
Price$0.00
Total Value$0
Shares Owned After2.16M
Transaction DateApr 1, 2026
Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Exercise · Acquire
Common Stock
Shares+2.82K
Price$0.00
Total Value$0
Shares Owned After2.13M
Transaction DateMar 31, 2026
Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Tax W/H · Dispose
Common Stock
Shares-1.43K
Price$92.37
Total Value$131.9K
Shares Owned After2.13M
Transaction DateMar 31, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-2.82K
Price$0.00
Total Value$0
Shares Owned After8.45K
Transaction DateMar 31, 2026
Footnotes ▸

This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter: March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. | Not applicable for Restricted Stock Units.

Post-Transaction Holdings

Talasaz AmirAli · Co-Chief Executive Officer, Director
SecuritySharesChange
Common Stock2.15M+18.02K (0.84%)
Restricted Stock Units68.01K-36.53K (-34.94%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-31 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Talasaz AmirAli CIK: 0001753159 Role: Director, Officer (Co-Chief Executive Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-03-31 | Code: M (Exercise of derivative) Shares: +2,817 | Price: $0.00 Shares Owned After: 2,131,306 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust [Transaction #2] Security: Common Stock Date: 2026-03-31 | Code: F (Payment of exercise/tax) Shares: -1,428 | Price: $92.37 Total Value: $131,904.36 Shares Owned After: 2,129,878 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. [Transaction #3] Security: Common Stock Date: 2026-04-01 | Code: M (Exercise of derivative) Shares: +23,997 | Price: $0.00 Shares Owned After: 2,153,875 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust [Transaction #4] Security: Common Stock Date: 2026-04-01 | Code: M (Exercise of derivative) Shares: +9,716 | Price: $0.00 Shares Owned After: 2,163,591 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust [Transaction #5] Security: Common Stock Date: 2026-04-01 | Code: F (Payment of exercise/tax) Shares: -17,087 | Price: $91.15 Total Value: $1,557,480.05 Shares Owned After: 2,146,504 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-03-31 | Code: M (Exercise of derivative) Shares: -2,817 | Price: $0.00 Shares Owned After: 8,451 | Ownership: D (Direct) Footnotes: [F2] This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter: March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. [F3] Not applicable for Restricted Stock Units. [Transaction #2] Security: Restricted Stock Units Date: 2026-04-01 | Code: M (Exercise of derivative) Shares: -23,997 | Price: $0.00 Shares Owned After: 71,992 | Ownership: D (Direct) Footnotes: [F4] This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. [Transaction #3] Security: Restricted Stock Units Date: 2026-04-01 | Code: M (Exercise of derivative) Shares: -9,716 | Price: $0.00 Shares Owned After: 68,011 | Ownership: D (Direct) Footnotes: [F5] This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. F2: This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter: March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026. F3: Not applicable for Restricted Stock Units. F4: This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F5: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz (2026-04-02)

keid analysis is for reference only and does not constitute investment advice.